Stage IVA Uterine Corpus Cancer AJCC v8

9 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Stage IVA Uterine Corpus Cancer AJCC v8

Record	Firm	Date
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax (NCT05092373)	M.D. Anderson Cancer Center	2022-04-29
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors (NCT05269381)	Mayo Clinic	2022-03-31
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors (NCT05039801)	M.D. Anderson Cancer Center	2021-09-30
Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer (NCT04269837)	Ohio State University Comprehensive Cancer Center	2021-05-20
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer (NCT04498520)	Pamela Munster	2021-03-31
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer (NCT04329494)	City of Hope Medical Center	2020-08-21
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)	City of Hope Medical Center	2019-12-24
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers (NCT03968406)	M.D. Anderson Cancer Center	2019-09-26
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma (NCT03008408)	M.D. Anderson Cancer Center	2017-08-18

Track Stage IVA Uterine Corpus Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.